Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid dosing in elective total hip or knee arthroplasty
2018-003537-15Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tranexamic acid in Bleeding (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Total perioperative blood loss. Started Jan 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on 2018-003537-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003537-15.